GP Bodey

634 total citations
12 papers, 512 citations indexed

About

GP Bodey is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, GP Bodey has authored 12 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 5 papers in Hematology. Recurrent topics in GP Bodey's work include Lymphoma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (3 papers). GP Bodey is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (3 papers). GP Bodey collaborates with scholars based in United States. GP Bodey's co-authors include EJ Freireich, MJ Keating, KB McCredie, Raymond Alexanian, EH Estey, S S Legha, Fernando Cabanillas, TL Smith, FB Hagemeister and Burgess Ma and has published in prestigious journals such as Blood.

In The Last Decade

GP Bodey

12 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
GP Bodey United States	8	350	223	172	113	59	12	512
Fred Richards United States	7	228 0.7×	188 0.8×	119 0.7×	99 0.9×	57 1.0×	11	427
D. H. Cowan Canada	12	186 0.5×	118 0.5×	100 0.6×	59 0.5×	61 1.0×	32	415
Ulrike Graubner Germany	14	145 0.4×	140 0.6×	148 0.9×	230 2.0×	46 0.8×	28	537
Hisaki Fujii Japan	15	176 0.5×	155 0.7×	143 0.8×	114 1.0×	39 0.7×	33	580
Bernard A. Ruether Canada	14	364 1.0×	135 0.6×	130 0.8×	32 0.3×	73 1.2×	21	519
J Hester United States	10	280 0.8×	198 0.9×	142 0.8×	43 0.4×	150 2.5×	16	507
Rosella Matera Italy	13	253 0.7×	147 0.7×	122 0.7×	70 0.6×	184 3.1×	28	472
G Prentice Australia	7	210 0.6×	103 0.5×	71 0.4×	63 0.6×	35 0.6×	13	387
Ralph Vogler United States	12	286 0.8×	185 0.8×	190 1.1×	151 1.3×	64 1.1×	19	458
P. Y. Leprise France	7	143 0.4×	358 1.6×	172 1.0×	173 1.5×	121 2.1×	8	575

Countries citing papers authored by GP Bodey

Since Specialization

Citations

This map shows the geographic impact of GP Bodey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GP Bodey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GP Bodey more than expected).

Fields of papers citing papers by GP Bodey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GP Bodey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GP Bodey. The network helps show where GP Bodey may publish in the future.

Co-authorship network of co-authors of GP Bodey

This figure shows the co-authorship network connecting the top 25 collaborators of GP Bodey. A scholar is included among the top collaborators of GP Bodey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GP Bodey. GP Bodey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Alexanian, Raymond, et al.. (1983). Prednisone pulse therapy for refractory myeloma. Blood. 62(3). 572–577. 71 indexed citations

2.

Alexanian, Raymond, et al.. (1983). Prednisone pulse therapy for refractory myeloma. Blood. 62(3). 572–577. 67 indexed citations

3.

Legha, S S, MJ Keating, KB McCredie, GP Bodey, & EJ Freireich. (1982). Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults. Blood. 60(2). 484–490. 85 indexed citations

4.

Legha, S S, MJ Keating, KB McCredie, GP Bodey, & EJ Freireich. (1982). Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults. Blood. 60(2). 484–490. 4 indexed citations

5.

Estey, EH, MJ Keating, KB McCredie, GP Bodey, & EJ Freireich. (1982). Causes of initial remission induction failure in acute myelogenous leukemia. Blood. 60(2). 309–315. 33 indexed citations

6.

Cabanillas, Fernando, FB Hagemeister, GP Bodey, & EJ Freireich. (1982). IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood. 60(3). 693–697. 8 indexed citations

7.

Estey, EH, MJ Keating, KB McCredie, GP Bodey, & EJ Freireich. (1982). Causes of initial remission induction failure in acute myelogenous leukemia. Blood. 60(2). 309–315. 158 indexed citations

8.

Cabanillas, Fernando, S S Legha, GP Bodey, & EJ Freireich. (1981). Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disorders. Blood. 57(3). 614–616. 1 indexed citations

9.

Cabanillas, Fernando, S S Legha, GP Bodey, & EJ Freireich. (1981). Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disorders. Blood. 57(3). 614–616. 21 indexed citations

10.

Keating, MJ, et al.. (1981). Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP). Blood. 58(3). 584–591. 55 indexed citations

11.

Cabanillas, Fernando, et al.. (1979). Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis. Blood. 54(6). 1249–1257. 3 indexed citations

12.

Cabanillas, Fernando, et al.. (1977). Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma. Blood. 49(3). 325–333. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact